TAIWAN: TAIFEX Receives CFTC’s Commission Certification for TIP Taiwan BIO Futures

Thursday January 21 2021

On 21^st January 2021, the Taiwan Futures Exchange (TAIFEX) announced that TIP Taiwan Market Biotechnology and Medical Care Index Futures contracts (TIP Taiwan BIO Futures, ticker symbol: BTF) have received Commission certification from the U.S. Commodity Futures Trading Commission (CFTC). The TIP Taiwan BIO Futures, launched on June 8, 2020, can now be offered and sold to persons located within the U.S.

As one of Taiwan’s industrial development priorities, biotech is the third largest sector in terms of trading value in Taiwan’s stock market, following the electronics and finance sectors. Currently, the TIP Taiwan BIO index consists of 60 constituents selected from biotechnology and medical care companies listed on the Taiwan Stock Exchange or the Taipei Exchange, with an upper limit of 20% on each constituents’ weight and 60% on the aggregate of the top five constituents’ weights. The launch of the TIP Taiwan BIO Futures has provided market participants a cost-efficient and effective tool to manage risks associated with the biotech industry in Taiwan.

Click on the above link for further information.